Seasoned MedTech Executive Brings Commercial and Strategic Leadership Experience to Accelerate Market Growth

SEATTLE, Nov. 12, 2026 /PRNewswire/ — Magnolia Medical Technologies, Inc., a leader in blood culture contamination prevention, announced the appointment of Roma Patel as Vice President, Marketing. Patel joins Magnolia’s executive leadership team and will lead the company’s marketing organization, focusing on market development, product and portfolio strategy, clinical education, and initiatives to accelerate adoption of the Steripath® platform.

Patel brings more than 20 years of experience across medical devices, diagnostics, and healthcare technology, with a background spanning marketing, commercial leadership, corporate strategy, and business development. Throughout her career, she has built high-performing teams, guided product commercialization, led expansion into new markets, and strengthened commercial performance.

Her executive experience includes serving as Chief Strategy Officer, Senior Vice President of Commercial Strategy, and Senior Vice President of Marketing at StimLabs, as well as Vice President of Marketing at Bako Diagnostics and StrataDx. She has also held strategic marketing and business development roles at Terumo Interventional Systems, Given Imaging (Medtronic), and C.R. Bard (BD), and advised healthcare organizations on corporate strategy, mergers and acquisitions, and commercial transformation.

“Roma brings a unique combination of marketing expertise, commercial leadership, and strategic business perspective,” said Jason Richey, President and Chief Executive Officer of Magnolia Medical. “She understands how to connect market insights, clinical value, and commercial execution to deliver results. As we continue expanding adoption of Steripath, her ability to align marketing with broader business priorities will be a tremendous asset to Magnolia. We’re excited to welcome her to our leadership team.”

“I am pleased to join Magnolia Medical at this important stage of its growth,” said Patel. “Magnolia has developed an innovative technology platform supported by compelling clinical evidence with a clear opportunity to improve patient care. I look forward to partnering with the leadership team to strengthen our market position, deepen engagement with healthcare providers, and bring the clinical and economic benefits of Steripath to more hospitals and patients.”

About Magnolia Medical

Magnolia Medical Technologies pioneered the blood culture diversion market and is a leader in blood culture contamination prevention. The company developed the Initial Specimen Diversion Device® (ISDD®) and the Steripath platform, helping hospitals reduce false-positive blood culture results, unnecessary treatments, and associated healthcare costs. Through clinical education and close partnerships with healthcare providers, Magnolia is committed to advancing best practices and improving patient outcomes. Headquartered in Seattle, Magnolia Medical holds more than 200 issued patents. Learn more at www.magnolia-medical.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/magnolia-medical-builds-executive-leadership-team-with-appointment-of-roma-patel-as-vice-president-marketing-302937150.html

SOURCE Magnolia Medical Technologies